reference/26480274

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26480274

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	712
issn	0302-2838
issueIdentifier	5
pageRange	706-712
publicationName	European Urology
startingPage	706
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d615ea26700ab56be8d18d4dd472c7df http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_15efc6190f3be0fb3582a4f2b162ac6c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a0a11ed5ae44cae153584230bd79287a
bibliographicCitation	Kearns JT, Faino AV, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y, Lin DW. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. European Urology. 2018 May;73(5):706–12. doi: 10.1016/j.eururo.2018.01.016.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40df825619529e19b4f08715ae8fe517 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3891dbbf9e66e0fcd347302a7aadbe11 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a8fee87dede95cb133b0cb919a0d082 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8503e1fbf599dd58d01d42e396fa2f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5d772ae9ea9562d5be9c70561806384 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76f4b4c1af032775aaa1a1d2542aa2b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f51620f52af69ceab1689e8be39c5457 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cee0b543434fd92f9b950470942b889 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db6a5215ed97dc1c9a78bd201c91389c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb7d57ddbd3fc2a38362d32d1a9227b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1e6934b3f4bb655cedcab76c9eb44b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57cb61b5b0f3302cbe34ed05748af8c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5416-4671 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60970449f1c62beea7b56f7f42339831
date	201805
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC6064187 https://pubmed.ncbi.nlm.nih.gov/29433973 https://doi.org/10.1016/j.eururo.2018.01.016
isPartOf	https://portal.issn.org/resource/ISSN/0302-2838 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3630
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study
discusses	http://id.nlm.nih.gov/mesh/M0026444 http://id.nlm.nih.gov/mesh/M0022149
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011471Q000145 http://id.nlm.nih.gov/mesh/D011471Q000473 http://id.nlm.nih.gov/mesh/D017430Q000097 http://id.nlm.nih.gov/mesh/D057832Q000379 http://id.nlm.nih.gov/mesh/D014408Q000097
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D058070 http://id.nlm.nih.gov/mesh/D009361Q000473 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D060787Q000379 http://id.nlm.nih.gov/mesh/D015999 http://id.nlm.nih.gov/mesh/D001707 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D016016 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D011471Q000628 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D015331 http://id.nlm.nih.gov/mesh/D007150
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8041 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fce276cc0efd2412c7dafdbb1e82fcc8

Total number of triples: 66.